Massimo Colombo

20.7k total citations · 4 hit papers
201 papers, 11.8k citations indexed

About

Massimo Colombo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Massimo Colombo has authored 201 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hepatology, 152 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Massimo Colombo's work include Liver Disease Diagnosis and Treatment (121 papers), Hepatitis C virus research (116 papers) and Hepatitis B Virus Studies (93 papers). Massimo Colombo is often cited by papers focused on Liver Disease Diagnosis and Treatment (121 papers), Hepatitis C virus research (116 papers) and Hepatitis B Virus Studies (93 papers). Massimo Colombo collaborates with scholars based in Italy, United States and France. Massimo Colombo's co-authors include E. Del Ninno, Michael Houghton, George Kuo, Q L Choo, Angelo Sangiovanni, Pietro Lampertico, Maria Francesca Donato, Maurizio Tommasini, N Dioguardi and Allan G. Redeker and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Massimo Colombo

198 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis

1989 2.7k citations Massimo Colombo et al. profile →
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

2012 1.2k citations Josep M. Llovet, Massimo Colombo et al. profile →
Hepatocellular Carcinoma in Italian Patients with Cirrhosis

1991 649 citations Massimo Colombo, Angelo Sangiovanni et al. profile →
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA

1989 559 citations Massimo Colombo, N Dioguardi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Colombo Italy	47	9.6k	8.5k	1.0k	1.0k	787	201	11.8k
Eiji Tanaka Japan	53	7.9k 0.8×	7.7k 0.9×	1.1k 1.1×	1.7k 1.7×	837 1.1×	280	11.2k
Namiki Izumi Japan	58	11.1k 1.2×	8.3k 1.0×	1.1k 1.1×	2.0k 2.0×	1.3k 1.7×	366	13.8k
Young‐Suk Lim South Korea	57	8.5k 0.9×	6.9k 0.8×	777 0.8×	1.9k 1.8×	1.4k 1.7×	336	11.0k
Pietro Andreoné Italy	49	7.7k 0.8×	7.1k 0.8×	571 0.6×	1.3k 1.3×	822 1.0×	346	9.9k
Fumitaka Suzuki Japan	54	9.6k 1.0×	9.1k 1.1×	778 0.8×	866 0.9×	612 0.8×	404	11.5k
Wan‐Long Chuang Taiwan	53	8.5k 0.9×	8.3k 1.0×	939 0.9×	732 0.7×	525 0.7×	513	11.1k
Françoise Degos France	42	6.5k 0.7×	6.7k 0.8×	1.2k 1.2×	729 0.7×	602 0.8×	145	9.1k
Masahiro Kobayashi Japan	57	11.3k 1.2×	9.8k 1.2×	1.7k 1.6×	1.4k 1.4×	1.7k 2.1×	473	15.3k
Francesco Negro Switzerland	64	12.4k 1.3×	12.2k 1.4×	1.4k 1.3×	823 0.8×	700 0.9×	311	16.0k
Robert G. Gish United States	68	12.4k 1.3×	12.4k 1.5×	1.4k 1.4×	1.8k 1.8×	691 0.9×	373	16.0k

Countries citing papers authored by Massimo Colombo

Since Specialization

Citations

This map shows the geographic impact of Massimo Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Colombo more than expected).

Fields of papers citing papers by Massimo Colombo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Colombo. The network helps show where Massimo Colombo may publish in the future.

Co-authorship network of co-authors of Massimo Colombo

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Colombo. A scholar is included among the top collaborators of Massimo Colombo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Colombo. Massimo Colombo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lazarus, Jeffrey V., Camila A Picchio, & Massimo Colombo. (2023). Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination. International Journal of Molecular Sciences. 24(18). 14404–14404. 16 indexed citations

Mura, Vincenzo La, Nicoletta Gagliano, Francesca Arnaboldi, et al.. (2022). Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia. Cells. 11(7). 1148–1148. 13 indexed citations

Jaffe, Ariel, et al.. (2022). Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International. 42(12). 2607–2619. 10 indexed citations

Valenti, Luca, Serena Pelusi, Cristiana Bianco, et al.. (2021). Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update. Hepatology Communications. 5(11). 1824–1832. 46 indexed citations

Colucci, Giuseppe, Roberta D’Ambrosio, E. Galmozzi, et al.. (2018). Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver Damage. Viral Immunology. 31(5). 358–361. 1 indexed citations

Aghemo, Alessio & Massimo Colombo. (2018). Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?. Gastroenterology. 154(4). 1195–1196. 11 indexed citations

Colombo, Massimo. (2015). Diagnosis of liver nodules within and outside screening programs. Annals of Hepatology. 14(3). 304–309. 5 indexed citations

Tuefferd, Marianne, Emanuele Palescandolo, Leen Vijgen, et al.. (2014). P1206 ITPA GENE VARIANTS AND ANEMIA DURING TELAPREVIR/PEGINTERFERON/RIBAVIRIN COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION. Journal of Hepatology. 60(1). S490–S490. 3 indexed citations

Vermehren, Johannes, Alessio Aghemo, Kai‐Henrik Peiffer, et al.. (2013). 506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS. Journal of Hepatology. 58. S208–S208. 2 indexed citations

10.

Hoshida, Yujin, Augusto Villanueva, Angelo Sangiovanni, et al.. (2013). Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis. Gastroenterology. 144(5). 1024–1030. 158 indexed citations

11.

Viganò, Mauro, Luca Valenti, Pietro Lampertico, et al.. (2013). Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Hepatology. 58(4). 1245–1252. 63 indexed citations

12.

Colombo, Massimo, Simone I. Strasser, Petr Urbánek, et al.. (2013). 806 MANAGEMENT AND OUTCOMES OF ANEMIA IN THE INTERNATIONAL TELAPREVIR EARLY ACCESS PROGRAM, FOR PATIENTS WITH HEPATITIS C GENOTYPE 1 INFECTION. Journal of Hepatology. 58. S329–S330. 5 indexed citations

13.

Viganò, Mauro, Claudia Vener, Pietro Lampertico, et al.. (2010). Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT. Bone Marrow Transplantation. 46(1). 125–131. 67 indexed citations

14.

Colombo, Massimo. (2009). Screening and diagnosis of hepatocellular carcinoma. Liver International. 29(s1). 143–147. 33 indexed citations

15.

Lalla, Claudia de, Grazia Galli, Luca Aldrighetti, et al.. (2004). Production of Profibrotic Cytokines by Invariant NKT Cells Characterizes Cirrhosis Progression in Chronic Viral Hepatitis. The Journal of Immunology. 173(2). 1417–1425. 121 indexed citations

16.

Monti, Maurilia Maria, et al.. (1999). TRANSGENIC TOMATOES EXPRESSING A CUCUMBER MOSAIC VIRUS SATELLITE RNA: FIELD TESTING AND ANALYSIS OF SATELLITE RNA SPREAD. Journal of Plant Pathology. 81(2). 113–122. 5 indexed citations

17.

Magnino, Simone, et al.. (1998). PCR diagnosis for Neospora caninum infection in aborted bovine fetuses and for Toxoplasma gondii infection in hares and goats in Italy. 1269–1272. 4 indexed citations

18.

Colombo, Massimo, P M Mannucci, Doreen B. Brettler, et al.. (1991). Hepatocellular carcinoma in hemophilia. American Journal of Hematology. 37(4). 243–246. 54 indexed citations

19.

Annoni, Giorgio, Maria Francesca Donato, Pietro Lampertico, et al.. (1988). Serum procollagen type III peptide levels in patients with acute viral hepatitis. La Ricerca in Clinica e in Laboratorio. 18(1). 37–44. 4 indexed citations

20.

Colombo, Massimo, Giorgio Annoni, Maria Francesca Donato, et al.. (1983). Serum Marker of Type III Procollagen in Patients with Idiopathic Hemochromatosis and Its Relationship to Hepatic Fibrosis. American Journal of Clinical Pathology. 80(4). 499–502. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact